Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
BMC Ophthalmology Oct 15, 2017
Hanhart J, et al. - As a part of this study, an examination was carried out of the mortality in patients treated with bevacizumab for wet age-related macular degeneration (AMD). The long-term mortality was raised in the wet AMD patients treated with bevacizumab compared to the same age and gender group without wet AMD.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
